Leuprolide Acetate for Injection (Depot 3.75 mg)
$300.00
| Quantity Value | Price | Quantity | Add To Cart |
|---|---|---|---|
| 6 Injection | $300.00 |
|
SKU : N/A
Category : Hormonal
Leuprolide Acetate for Injection is a long-acting GnRH agonist used to manage hormone-dependent conditions by suppressing estrogen or testosterone levels under medical supervision.
Product Overview
Leuprolide Acetate for Injection (Depot 3.75 mg) is a long-acting injectable medication belonging to the class of gonadotropin-releasing hormone (GnRH) agonists. It is specifically designed to regulate hormone production in the body and is commonly prescribed in conditions where suppression of sex hormones, such as estrogen or testosterone, is medically necessary. The depot formulation allows for sustained release of the active ingredient over an extended period, reducing the frequency of administration compared with short-acting formulations. This medicine is intended for use under the supervision of a qualified healthcare professional to ensure safety and efficacy.
Mechanism of Action
Leuprolide Acetate for Injection (Depot 3.75 mg) works by targeting the pituitary gland, a critical regulator of reproductive hormone production. Upon initial administration, it stimulates the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). However, with continued dosing, the pituitary’s GnRH receptors become downregulated, leading to a significant reduction in the production of sex hormones—testosterone in males and estrogen in females. This hormonal suppression is clinically beneficial in managing hormone-dependent medical conditions, as it slows disease progression and helps control symptoms associated with elevated hormone levels.
Indications and Uses
Leuprolide Acetate for Injection (Depot 3.75 mg) is indicated for the treatment of several hormone-sensitive conditions. In men, it is commonly used in advanced prostate cancer, where lowering testosterone levels can slow tumor growth and improve patient outcomes. In women, it is indicated for endometriosis, where reducing estrogen levels helps relieve pain and minimize the progression of ectopic endometrial tissue. It is also used in the preoperative management of uterine fibroids, helping shrink fibroid size before surgery. Additionally, Leuprolide Acetate is approved for central precocious puberty, delaying the onset of puberty in children diagnosed with this condition. The choice of indication, dosage, and treatment duration depends on the patient’s clinical profile and the prescribing physician’s evaluation.
Composition
The active ingredient in this formulation is Leuprolide Acetate for Injection (Depot 3.75 mg), a synthetic nonapeptide analog of natural GnRH. It is provided as a sterile depot injection, formulated to release the medication gradually after intramuscular administration. This slow release ensures consistent hormonal suppression over several weeks. Inactive components, such as biodegradable polymers and stabilizing agents, are included to maintain the stability of the depot formulation and facilitate sustained drug delivery.
Administration
Leuprolide Acetate for Injection (Depot 3.75 mg) is administered via intramuscular injection by a healthcare professional. Because of its long-acting depot formulation, it is typically given at specific intervals determined by the treating physician. Patients should not attempt self-injection unless specifically trained and advised by a medical professional. Throughout the course of treatment, regular monitoring is recommended to assess therapeutic response and detect any potential adverse effects.
Storage Instructions
Leuprolide Acetate for Injection (Depot 3.75 mg) should be stored according to the instructions on the product label, typically in a cool, dry place away from direct light. Freezing is not recommended unless explicitly stated. The product should be kept out of reach of children. Proper storage helps maintain the stability, potency, and safety of the medication.
Important Information and Warnings
Leuprolide Acetate for Injection (Depot 3.75 mg) should only be used under strict medical supervision. Patients may experience a temporary worsening of symptoms at the beginning of treatment due to initial hormonal stimulation. Individuals with a history of osteoporosis, cardiovascular disease, or metabolic disorders should inform their healthcare provider prior to starting therapy. Regular follow-up appointments, including laboratory monitoring, may be necessary to ensure the medication is effective and safe. This medicine is not recommended during pregnancy or breastfeeding unless clearly advised by a physician.
For additional medically reviewed information, patients can refer to MedlinePlus: Leuprolide Injection.
| Pack Size |
6 Injection |
|---|
